Charles A. Hunter, Jr. Prize Thesis Award
(1984-present)

1984: Relationship of Fetal Oxygen Consumption and Acid-Base Balance to Fetal Hematocrit; Daniel I. Edelstone, MD, Pittsburgh, Pennyslvania

1985: Biochemical and Physiological Characterization of Follicle Regulatory Protein: A Paracrine Regulator of Folliculogenesis; Gere S. diZerega, MD, University of Southern California

1986: Altered Life Span and Function of Peritoneal Macrophages: A New Hypothesis for Pathogenesis of Endometriosis; Jouko K. Halme, MD, PhD, University of North Carolina

1987: Selective Inhibition of C-MYC Expression in JEG-13 Choriocarcinoma Cells by the RNA Synthesis Inhibitor, Mithramycin; Vicki V. Baker, MD, Birmingham, Alabama

1988: The Development of Alpha Emitting Radionuclide Lead-212 for the Potential Treatment of Ovarian Carcinoma; Jacob Rotmensch, MD, Chicago, Illinois

1989: Hunter Prize was not awarded

1990: Immunomodulation with Calcium Blockade Enhances Reproductive Performance in an Animal Model; Alex Steinleitner, MD, Miami Beach, Florida

1991: Evidence of Embryo-And Trophoblast-Toxic Cellular Immune Response (S) in Women with Recurrent Spontaneous Abortion; Joseph A. Hill, III, MD, Boston, Massachusetts

1992: Analysis of Cystic Fibrosis Mutations in Caucasians and African-Americans: An Approach to Identification of Unknown Mutations and Implications for Cystic Fibrosis Screening; Owen P. Phillips, MD, Memphis, Tennessee

1993: Spectrum of Mutation and Frequency of Allelic Deletion of the P53 Gene in Ovarian Cancer; Andrew Berchuck, MD, Durham, North Carolina

1994: Strategies to Respond to Polymerase Chain Reaction DNA Amplification Failure in A Pre-Implanation Genetic Diagnosis Program; William E. Gibbons, MD, Norfolk, Virginia

1995: Transgene Expression in the Rhesus Cervix Mediated by an Adenovirus Expressing B-Galactosidase; Michele Follen Mitchell, MD, Houston, Texas

1996: Estrogen Regulation of Adipose Tissue Lipoprotein Lipase – Possible Mechanism of Body Fat Distribution; Thomas M. Price, MD, Greenville, South Carolina

1997: Field Cancerization: Why Late Recurrent Ovarian Cancer Isn’t Recurrent; Richard E. Buller, MD., PhD, Iowa City, Iowa

1998: Increased Heterogeneity of Chromosome 17 Aneuploidy in Endometriosis; Yoshinori Kosugi, MD, Tokyo, Japan

1999: Expression of Dioxin-Related Trans-Activating Factors and Target Genes in Human Endometrium and Endometriosis; Serdar E. Bulun, MD, Dallas, Texas

2000: Molecular Tools to Re-estabish Progestin Control of Endometrial Cancer Cell Proliferation; Kimberly K. Leslie, MD, Colorado Springs, Colorado

2001: MEETING CANCELLED.

2002: Surgical Skills Assessment: A Blinded Examination of Obstetrics and Gynecology Residents; Barbara A. Goff, MD, Seattle, Washington

2003: Functional Role of Matrix Metalloproteinases in Ovarian Tumor Cell Plasticity; Anil K. Sood, MD, Houston, Texas

2004: Programmed Syndrome of Hypernatremic Hypertension in Ovine Twin Lambs, Michael G. Ross, MD, MPH, Los Angeles, California

2005: Hunter Prize was not awarded.

2006: Progestin Inhibits and Thrombin Stimulates the Plasminogen Activator/Inhibitor System in Term Decidual Stromal Cells: Implications for Parturition; Errol R. Norwitz, MD, PhD, New Haven, Connecticut

2007: Cost effectiveness analysis of annual screening tests for patients at high risk of endometrial cancer; Laura J. Havrilesky, MD, Durham, North Carolina